ALXA

Alexza Pharmaceuticals, Inc. News Headlines

$2.54
*  
0.16
5.93%
Get ALXA Alerts
*Delayed - data as of Sep. 22, 2014  -  Find a broker to begin trading ALXA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Insomnia Found to Cost $63 Billion a Year - Here are 4 Companies to Treat It
10/11/2011 7:09:06 PM - Kapitall

Alexza's Agitation Drug Back Under Review - Trade the Upcoming Catalysts
8/9/2011 2:11:00 PM - Seeking Alpha

5 Healthcare Company Updates Released Wednesday
7/28/2011 8:36:00 AM - Seeking Alpha

Alexza Pharmaceuticals: Stock Moving Events for Second Half 2011
7/19/2011 4:42:00 PM - Seeking Alpha

6 Healthcare Companies With July Catalysts
6/30/2011 4:01:00 PM - Seeking Alpha

Biotech Catalysts for Third Quarter
6/24/2011 6:34:00 PM - Seeking Alpha

12 Rallying Stocks Under $5 Undervalued by Analysts
6/24/2011 5:06:00 PM - Seeking Alpha

Biotech: Some CRL Recipients to Consider
5/16/2011 10:18:00 AM - Seeking Alpha

Dow Nears 2011 Highs
3/31/2011 3:29:00 AM - Seeking Alpha

All Eyes on Alexza as Company Prepares to Re-File Drug Application
3/16/2011 1:59:00 PM - Seeking Alpha

The Market Seems to Disagree With Alexza's Promising News
1/19/2011 3:39:00 AM - Seeking Alpha

A New Deal for Alexza Could Present Opportunity for Investors
1/19/2011 2:56:00 AM - Seeking Alpha

Biotech’s Top and Bottom 10 From 2010
1/6/2011 10:58:00 AM - Seeking Alpha

FDA Locked And Loaded For MELA Sciences (MELA, VVUS, ARNA, ALXA, MDT, SYK)
11/16/2010 12:27:00 PM - Investopedia

Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
10/17/2010 8:39:00 AM - Seeking Alpha

Alexza's CRL Offers Long Term Investment Opportunity
10/12/2010 11:13:00 AM - Seeking Alpha

Risks vs. Benefits in Holding Alexza Through Approval of AZ-004
10/11/2010 6:55:00 AM - Seeking Alpha

Alexza Pharmaceuticals: Hold, Sell, or Put?
10/3/2010 9:47:00 AM - Seeking Alpha

Roche Dominates the Biotech Deal Flow
8/30/2010 6:43:00 AM - Seeking Alpha

Alexza Pharma Clears Hurdles Towards Approval for Agitation Drug
8/18/2010 1:18:00 AM - Seeking Alpha

Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals
8/8/2010 8:34:00 AM - Seeking Alpha

Alexza Financing Will Help Near-Term Milestones and Product Launch
8/7/2010 11:15:00 AM - Seeking Alpha

A Closer Look at the Biovail - Valeant Merger
6/23/2010 3:34:39 AM - SeekingAlpha

VC-Backed Life Sciences Companies Get Fresh Cash
5/30/2010 11:19:00 AM - Seeking Alpha

Medtech Brings in Life Sciences Venture Dollars
5/9/2010 6:40:00 PM - Seeking Alpha